Skip to the main content.
    Request Demo

    Resources

    Your Hub Program Can’t Succeed Without Both High-Tech and High-Touch Support
    In the fast-paced world of specialty drug access, you need both people and technology to give patients the ideal level...
    Is Your Hub Underperforming in Reverification Season? Discover How CareMetx Leads the Way
    The annual reverification season demands flawless execution, but many well-known hub providers repeatedly fall short....
    Drug Channels: No More Delays--Accelerating Therapy Starts by Embedding Hub Services in Provider Workflows
    Timely access to therapy is crucial for improving health outcomes. However, most healthcare providers struggle with...

    In the News

    Here’s Why You Should Retain Allscripts (MDRX) Stock For Now
    Allscripts Healthcare Solutions, Inc. MDRX is well-poised for growth in the coming quarters, backed by its strategic...
    A Conversation with Mark Hansan, CareMetx
    CareMetx was founded in 2011 by two longtime industry executives, Bob Dresing and Mark Hansan, who started in the...
    Value-based agreements could disrupt how we pay for new therapies
    On Tuesday, the Senate Finance Committee will hold its second hearing in a series on drug pricing. Led by chairman...

    Press Releases

    CareMetx Welcomes Scott Genone as Chief Product Officer
    Genone brings over 30 years of healthcare technology leadership, set to elevate product innovation and patient access....
    CareMetx Receives US Patent for Automated Manufacturer Program Patient Enrollment Tool
    Bethesda, MD, September 24, 2024 – CareMetx, a leading technology-enabled hub services platform facilitating patient...
    CareMetx Acquires PX Technology to Reshape Patient Access to Specialty Medications and Drive Efficiency Across Healthcare Ecosystem
    Acquisition combines CareMetx’s high-touch patient support services with PX Technology’s advanced digital access...

    Case Studies

    Case Study: CareMetx Facilitates Seamless Vaccine Access While Outperforming SLA Criteria
    This global biopharmaceutical company worked with CareMetx to improve patient access to two of its vaccines. CareMetx's...
    CareMetx Leverages AI and Best Practices to Complete 450k+Annual Reverifications Accurately and Ahead of Schedule
    CareMetx employed AI and best practices to expedite over 450,000 annual reverifications (AR), ensuring patients receive...
    Case Study: CareMetx leveraged specialized patient support services to help navigate the hurdles associated with biosimilar products.
    CareMetx leveraged specialized patient support services to help navigate the hurdles associated with biosimilar...